Inés de Lannoy | Vice President, Research and Development
As Vice President of Research and Development, Inés brings both pharmacokinetics (PK) and drug discovery experience to IVS, having worked at a number of biopharmaceutical and contract research organizations (CROs) over the past 25 years. She was responsible in her previous role at two CROs, for building the in vivo PK, in vitro ADME, high throughput screening and bioanalytical capabilities of the companies, for offering as a service to pharmaceutical clients. While at Allelix Biopharmaceuticals (now NPS Pharmaceuticals), she helped advance several drug candidates from discovery into clinical trials. Inés strives to develop new pre-clinical models/methods for the more accurate and facile characterization of human PK. Her expertise in the transport of xenobiotics across the blood-brain barrier, an area in which she has a keen research interest, is a valuable asset to IVS clients. Inés obtained a Ph.D. in drug and metabolite PK from the University of Toronto and did post-doctoral fellowships at Harvard Medical School and University of Toronto. She currently holds the position of Assistant Professor (status) and Associate Graduate Faculty Member in the Graduate Department of Pharmaceutical Sciences at the Leslie Dan Faculty of Pharmacy, University of Toronto. She currently serves on the editorial board of Biopharmaceutics and Drug Disposition and is an associate editor for Current Protocols in Pharmacology.